Alpha 2.0
Login Register
» Articles » PMID: 32371477

Rapid Implementation of Mobile Technology for Real-time Epidemiology of COVID-19

Overview
Journal Science
Specialty Science
Date 2020 May 7
PMID 32371477
Citations 193
Authors
David A Drew
Long H Nguyen
Claire J Steves
Cristina Menni
Maxim Freydin
Thomas Varsavsky
Carole H Sudre
M Jorge Cardoso
Sebastien Ourselin
Jonathan Wolf
Tim D Spector
Andrew T Chan
Affiliations
Soon will be listed here.
Abstract

The rapid pace of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents challenges to the robust collection of population-scale data to address this global health crisis. We established the COronavirus Pandemic Epidemiology (COPE) Consortium to unite scientists with expertise in big data research and epidemiology to develop the COVID Symptom Study, previously known as the COVID Symptom Tracker, mobile application. This application-which offers data on risk factors, predictive symptoms, clinical outcomes, and geographical hotspots-was launched in the United Kingdom on 24 March 2020 and the United States on 29 March 2020 and has garnered more than 2.8 million users as of 2 May 2020. Our initiative offers a proof of concept for the repurposing of existing approaches to enable rapidly scalable epidemiologic data collection and analysis, which is critical for a data-driven response to this public health challenge.

Citing Articles

Is joint hypermobility linked to self-reported non-recovery from COVID-19? Case-control evidence from the British COVID Symptom Study Biobank.

Eccles J, Cadar D, Quadt L, Hakim A, Gall N, Bowyer V BMJ Public Health. 2025; 2(1):e000478.

PMID: 40018183 PMC: 11812800. DOI: 10.1136/bmjph-2023-000478.

Systematic Review of Usability Factors, Models, and Frameworks with Blockchain Integration for Secure Mobile Health (mHealth) Applications.

Feroz I, Ahmad N Blockchain Healthc Today. 2025; 7.

PMID: 39995486 PMC: 11848842. DOI: 10.30953/bhty.v7.357.

HealthPass: a contactless check-in and adaptive access control system for lowering cluster infection risk in public health crisis.

Luo G, Wang Y, Hong L, He X, Wang J, Shen Q Front Public Health. 2024; 12:1448901.

PMID: 39735762 PMC: 11672792. DOI: 10.3389/fpubh.2024.1448901.

A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.

Bhai S, Levine T, Moore D, Bowser R, Heim A, Walsh M Muscle Nerve. 2024; 71(1):63-72.

PMID: 39511965 PMC: 11632565. DOI: 10.1002/mus.28287.

Vaping habits and respiratory symptoms using a smartphone app platform.

Lee M, Eum K, Allen J, Onnela J, Christiani D BMC Public Health. 2024; 24(1):2047.

PMID: 39080563 PMC: 11289986. DOI: 10.1186/s12889-024-19439-0.

References
1.
Menni C, Valdes A, Freidin M, Sudre C, Nguyen L, Drew D . Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020; 26(7):1037-1040. PMC: 7751267. DOI: 10.1038/s41591-020-0916-2. View
2.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View
3.
Xu X, Wu X, Jiang X, Xu K, Ying L, Ma C . Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368:m606. PMC: 7224340. DOI: 10.1136/bmj.m606. View
4.
Drew D, Nguyen L, Steves C, Menni C, Freydin M, Varsavsky T . Rapid implementation of mobile technology for real-time epidemiology of COVID-19. Science. 2020; 368(6497):1362-1367. PMC: 7200009. DOI: 10.1126/science.abc0473. View
5.
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S . Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020; 180(7):934-943. PMC: 7070509. DOI: 10.1001/jamainternmed.2020.0994. View